secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioAtla, Inc. (BCAB)
CIK:        0001826892
Form:       8-K
Filed at:   2023-01-06T23:59:59+00:00
Accession:  0001193125-23-003550
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioAtla enters $100M ATM equity offering with Jefferies
-------------------------------------------------------

- Up to $100M aggregate gross sales proceeds from common stock sold through Jefferies as sales agent.
- Jefferies will receive 3% commission on gross proceeds; company reimburses certain expenses.
- Company has no obligation to sell shares; may suspend offering at any time.
- Shares issued under existing effective shelf registration statement (File No. 333-262528).
- Offering terminates upon sale of all shares or termination of agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1826892/000119312523003550/0001193125-23-003550-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1826892/000119312523003550/d437048d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-003550

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer